Member Info for desamax

Prof. Ali Jaber Nima, from the Surgery Branch at the Faculty of Medicine at the University of Kufa, and Assistant Professor Dr. Israa Abdel -Al Salman, from the branch of diseases and forensic medicine in the same college, was a patent from the Central Agency for Standardization and Quality Control of the Ministry of Planning, on the innovation of a new target treatment for multiple types of cancer.

The innocence included the development of the SRA 737 Checkpointkinase1 inhibitor, an innovative treatment targeting non -small cell lung cancer, as well as colon and rectum cancer cells, through a mechanism based on disabling cellular checkpoints on which cancer cells depend on growth and division.

This scientific achievement represents an important step in the field of cancer research and directed molecular therapy, and reflects the pioneering role of the University of Kufa in supporting medical research with a direct therapeutic effect.

Hoping to see a flood of late trades after hours.

OBD

https://x.com/smallcappixuk/status/1934903558438072331?s=46&t=n0JudCHwixodxyZsJ2WdKg

Https://x.com/smallcappixuk/status/1934903558438072331?s=46&t=n0JudCHwixodxyZsJ2WdKg

Having recently had the dreaded invasive degrading biopsy, I can’t tell you what this test would mean the the majority of men. No one forgets the biopsy.

Got to be worth a punt, but only if you can afford it!

Good after noon all, been out the loop with more important health issues for most of this year. I try to read LSE often as possible, wondered if the question about whether the bod was looking for a new CEO and if so are they making any progress? Or has the bod mentioned since Tim’s step down any sort of criteria ?

Https://www.investormeetcompany.com/meetings/half-year-results-104

Click on Q&A

It appears the scores of interested parties have all become disinterested over the years been a long slog since the covid grant uplift that fizzed out without a proper explanation, rinse and repeat, the board need proper negotiators as they only have scientific skills and not much else on the marketing side. .

Remember this Parker quote from the link below

“ Delighted that @Sareumplc has been supported to complete the phase Ia trial for SDC-1801 - we have great shareholders!”

“WE HAVE GREAT SHAREHOLDERS” 🤔

https://x.com/sparksinsurrey/status/1773254067243860377?s=46&t=n0JudCHwixodxyZsJ2WdKg

Https://youtu.be/YM9pyx0tr2U?si=jW4VwNnOEqe8UUg8

Anyone been able to get log in details or is this private presentation?

Co-founder and COO, Dr Tim Mitchell looks forward to presenting Phase 1 clinical data from Sareum Ltd's SDC-1801 TYK2/JAK1 kinase inhibitor for autoimmune diseases programme at the #LSX #Investival Showcase in London on Monday November 18. Presentation is at 11.45 in the Biotech Public stream. https://lnkd.in/eP7Cz4CS

Are they not broadcasting the recording of todays presentation?

Really happy to hear your fantastic news. RICH3R, I’m just starting on the same journey , was given the news that I have GG2. My beautiful wife made me go doctors and she may have saved my life by them detecting it earlyish. Please guys especially if your over 50 get a check or blood test.

No good earwigging over the garden fence anymore.

She’s gone. LOL

Pork’s you know the last half hour will be crazy with FOMO once the presentation has been viewed and the herd pile in first thing tomorrow. Get in now and beat the herd. Don’t be like the man who fell out the balloon.

Great buy in opportunity under 2p today. Watch the presentation and if you like what you hear jump in. But be quick it’s not hanging around.

Would anyone like to guess what expected price T2 would put on this today?

Https://www.aacr.org/professionals/research-funding/grantees/jeffrey-engelman-and-the-mitzvah-of-cancer-research/

Could this be the cofounder who helped write this article?

https://www.tandfonline.com/doi/abs/10.4161/cc.8.1.7324